ClinicalTrials.gov record
Completed Phase 2 Interventional

Study of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intolerant to Statins Due to Statin-associated Myalgia (SAM)

ClinicalTrials.gov ID: NCT01279590

Public ClinicalTrials.gov record NCT01279590. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 1:31 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled and Active-comparator-controlled Phase 2b Study to Evaluate Statin-associated Myalgia Incidence, Lipid Profile Effect, and Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients With Primary Hypercholesterolemia, Fredrickson IIa or IIb, Who Have Discontinued Two or More Prior Statin Therapies Due to Statin-associated Myalgia

Study identification

NCT ID
NCT01279590
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Furiex Pharmaceuticals, Inc
Industry
Enrollment
282 participants

Conditions and interventions

Interventions

  • Atorvastatin Drug
  • PPD10558 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Oct 31, 2011
Completion
Oct 31, 2011
Last update posted
Dec 21, 2011

2011

United States locations

U.S. sites
67
U.S. states
29
U.S. cities
63
Facility City State ZIP Site status
Furiex research site Anniston Alabama 36207
Furiex research site Phoenix Arizona 85018
Furiex research site Phoenix Arizona 85023
Furiex research site Huntington Park California 90255
Furiex research site Long Beach California 90806
Furiex research site Pismo Beach California 93449
Furiex research site San Diego California 92103
Furiex research site West Lake Village California 91361
Furiex research site Colorado Springs Colorado 80907
Furiex research site Golden Colorado 80401
Furiex research site Hartford Connecticut 06102
Furiex research site Boynton Beach Florida 33472
Furiex research site Coral Gables Florida 33134
Furiex research site Deerfield Beach Florida 33441
Furiex research site Fort Lauderdale Florida 33308
Furiex research site Gainesville Florida 32605
Furiex research site Opa-locka Florida 33054
Furiex research site Pembroke Florida 33024
Furiex research site Pembroke Florida 33028
Furiex research site Sanford Florida 32771
Furiex research site West Palm Beach Florida 33401
Furiex research site Honolulu Hawaii 96814
Furiex Research site Boise Idaho 83704
Furiex research site Nampa Idaho 83686
Furiex research site Chicago Illinois 60616
Furiex research site Mission Kansas 66202
Furiex research site Madisonville Kentucky 42431
Furiex research site Covington Louisiana 70433
Furiex research site Auburn Maine 04210
Furiex research site Oxon Hill Maryland 20745
Furiex research site Bay City Michigan 48706
Furiex research site St Louis Missouri 63117
Furiex research site Billings Montana 59101
Furiex research site Butte Montana 59701
Furiex research site Missoula Montana 59808
Furiex research site Omaha Nebraska 68144
Furiex research site Great Neck New York 11023
Furiex research site Asheville North Carolina 28803
Furiex research site Cary North Carolina 27518
Furiex research site Charlotte North Carolina 28209
Furiex research site Harrisburg North Carolina 28075
Furiex research site Hickory North Carolina 28601
Furiex research site Hickory North Carolina 28602
Furiex research site High Point North Carolina 27262
Furiex research site Raleigh North Carolina 27609
Furiex research site Raleigh North Carolina 27612
Furiex research site Wilmington North Carolina 28401
Furiex research site Carlisle Ohio 45005
Furiex research site Cincinnati Ohio 45236
Furiex research site Columbus Ohio 43213
Furiex research site Kettering Ohio 45429
Furiex research site Springfield Ohio 45505
Furiex research site Altoona Pennsylvania 16602
Furiex research site Johnstown Pennsylvania 15905
Furiex research site Cumberland Rhode Island 02864
Furiex research site East Providence Rhode Island 02914
Furiex research site Anderson South Carolina 29621
Furiex research site Greenville South Carolina 29605
Furiex research site Greer South Carolina 29651
Furiex research site Mt. Pleasant South Carolina 29464
Furiex research site Pawleys Island South Carolina 29585
Furiex research site Bristol Tennessee 37620
Furiex research site Tomball Texas 77375
Furiex research site Salt Lake City Utah 84124
Furiex research site Norfolk Virginia 23502
Furiex research site Richmond Virginia 23294
Furiex Spokane Washington 99208

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01279590, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2011 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01279590 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →